If you've ever been going about your day only to get hit with excruciating joint pain, it could be gout. While this type of ...

Leading herbal medicine experts from the University of the Philippines Manila have developed an anti-gout tablet derived from ...

Summary. Febuxostat is a novel non-purine selective inhibitor of xanthine oxidase for the management of hyperuricemia in patients with gout. The ability of febuxostat to decrease serum uric acid ...

Febuxostat is a second-line option for patients with gout who are unable to take allopurinol ... Febuxostat is not recommended for the treatment of patients with secondary hyperuricemia, such ...

Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882: San Diego Wednesday, March 19, 2025, 11:00 Hrs [IST] Arthrosi Therape ...

Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, ...

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics ...

Hyperuricemia (HU), characterized by elevated uric acid (UA) levels in the blood, is a global health concern associated with various conditions, including cardiovascular diseases, gout, hypertension, ...

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Fra ...

This partnership underscores the rising importance of lithium in various sectors, from energy storage to pharmaceuticals.

Australian sprinting sensation Gout Gout made headlines again on Sunday by clocking the fastest men’s 200m time in the world this year. The 17-year-old described his race as feeling "literally free" ...